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INTRODUCTION
Equine	strongyles	research	and	analysis	is	an	
important	 topic	 due	 to	 the	 very	 high	 morbidity	
(up	 to	 99%)	 and	 the	 serious,	 sometimes	 fatal,	
repercussions	of	the	infection	(Cernea	et al.,	2010;	
Cernea	et al.,	2015;	Smith	et al.,	2015).	
Strongyles	 can	 alter	 the	 animal’s	 behaviour,	
fertility,	 physical	 condition,	 development,	
reducing	 its	 resistance	 to	 other	 pathogens	 or	
even	 cause	 death.	 The	 large	 number	 of	 species,	
varying	 ontogenesis	 and	 problems	 related	 to	
diagnosis	 turn	 this	 pathology	 into	 a	 permanent	
challenge	 for	 both	 veterinarians	 and	 equine	
owners	 (Cernea	 et al.,	 2010;	 King	 et al.,	 1990,	
Madeira	de	Carvalho	et al.,	2014).	In	addition,	the	
development	 of	 anthelmintics	 resistance,	 along	
with	the	high	costs	required	for	finding	new	drugs	
force	 the	 researchers	 try	 to	 find	 new	 ways	 in	
approaching	diagnosis,	treatment	and	prevention	
of	this	pathology	(Cernea	et al.,	2010,	Madeira	de	
Carvalho	et al.,	2003).	
Our	research	aimed	to	assess	the	effectiveness 
of	 four	 benzimidazoles:	 albendazole	 (ABZ),	
fenbendazole	 (FBZ),	 mebendazole	 (MBZ)	 and	
thiabendazole	(TBZ)	against	equine	strongyles.
MATERIAL AND METHODS
The tests	 were	 performed	 between	 March	
2015	 and	 May	 2016	 on	 samples	 obtained	 from	
two	 groups	 of	 animals	 living	 in	 Tomeşti	 village,	
Harghita	County.	
Benzimidazoles Pharmacodynamics in Equine 
Strongyles
Laura	CĂTANĂ*,	Csongor	OLÁH,	Raul	CĂTANĂ,	Mihai	CERNEA	
University	of	Agricultural	Sciences	and	Veterinary	Medicine	Cluj-Napoca,	Faculty	of	Veterinary	
Medicine,	Calea	Manastur	3-5,	400372,	Cluj-Napoca,	Romania
*corresponding	author:	laura.catana@usamvcluj.ro
Bulletin	UASVM	Veterinary	Medicine	73(2)	/	2016,	
Print	ISSN	1843-5270;	Electronic	ISSN	1843-5378
DOI:10.15835/buasvmcn-vm:	12230
Abstract
Our	research	aimed	to	assess	the	effectiveness	of	four	benzimidazoles:	albendazole,	fenbendazole,	mebendazole	
and	thiabendazole	against	equine	strongyles.	The	tests	were	performed	between	March	2015	and	May	2016,	on	
samples	collected	from	20	horses	and	8	donkeys	living	in	Harghita	County.	In vivo,	Faecal	Egg	Count	Reduction	
Test (FECRT) was	used	to	evaluate	fenbendazole	pharmacodynamics.	In vitro,	Egg	hatch	assay	(EHA) and Larval	
development	 assay	 (LDA)	were	 used	 to	 evaluate	 the	 effectiveness of	 albendazole,	 fenbendazole,	mebendazole	
and	 thiabendazole.	 The	predominance	 of	 small	 strongyle	 species	was	 observed,	mostly	Cyathostomum type	A.	
In	 the	 horse	 group,	 before	 treatment,	 the	 average	 intensity	was	 1595.5	 EPG,	 the	maximum	value	 being	 4000,	
and	extensivity	55%.	Tested	again	at	14	days	after	 treatment,	all	 samples	were	negative.	 In	 the	donkey	group,	
before	 treatment,	 the	 total	 number	was	 6550	 EPG,	 intensity	 of	 935.7	 and	 extensivity	 of	 87.5%.	 14	 days	 after	
treatment,	the	average	intensity	was	150	and	the	extensivity	50%.	In	the	horse	group,	EHA	proved	the	efficacy	
of	 fenbendazole	 (0.0192%),	 albendazole	 (0.3740%)	and	 thiabendazole	 (11.62%)	and	a	major	 risk	of	 inducing	
adaptive	phenomena	for	mebendazole	(Y	parameter	1009.92).	In	the	donkey	group,	all	benzimidazoles	had	limited	
effectiveness:	thiabendazole	(73.93%),	mebendazole	(87.51%),	fenbendazole	(94.05%),	albendazole	(111.67%).	
All	benzimidazoles	inhibited	larval	development.	For	all	tested	benzimidazoles,	the	resistance	induction	predictive	
comparative	risk	analysis	highlighted	the	benefit	of	their	use,	provided	that	the	treatment	protocol	allows	sufficient	
contact	time.
Keywords: benzimidazoles, equines, resistance, strongyles.
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Group	1	was	constituted	of	20	horses	aged	6	
months	to	16	years	and	Group	2	was	constituted	
of	8	donkeys	aged	7	months	to	19	years.
In vivo,	 we	 used	 the	 Faecal	 Egg	 Count	
Reduction	Test (FECRT) in	 order	 to	 evaluate	 the	
fenbendazole	effectiveness.	
In vitro,	in	order	to	evaluate	the	effectiveness	
of	 albendazole,	 fenbendazole,	 mebendazole	 and	
thiabendazole,	 two	 tests	 were	 used:	 Egg	 Hatch	
Assay	(EHA) and Larval	Development	Assay	(LDA).
Six	 months	 prior	 to	 this	 study,	 in	 the	 horse	
group,	 ivermectin-based	 products	 treatments	
were	 carried	 out.	 No	 recorded	 data	 regarding	
the	anthelmintic	treatments	of	the	donkey	group	
is	 available.	 For	 accuracy,	 faecal	 samples	 were	
collected	 directly	 from	 the	 rectal	 ampulla	 or	
immediately	 after	 defecation.	 For	 each	 of	 the	
collected	 samples,	 McMaster	 and	 Stoll	 methods	
and	coprocultures	were	performed.
FECRT	aimed	to	assess	the	strongyles	intensity	
and	 extensivity	 before	 (BT)	 and	 post-treatment	
(PT),	 evaluation	 of	 fenbendazole	 effectiveness in 
vivo,	 statistical	 analysis	of	 the	obtained	data	and	
identification	of	the	resistant	strongyle	species.
For	 EHA,	 we	 used	 serial	 dilutions	 from	 500	
mcg	 to	 0.98	 mcg	 active	 ingredient/ml.	 In	 order	
to	 evaluate	 the	 strongyles	 resistance	 against	
benzimidazoles,	 the	 following	 parameters	 were	
interrelated:	 hatching	 percentage	 and	 larval	
development	 at	 the	 reference	 concentration,	 the	
trendline	 equation,	 lethal	 concentration	 for	50%	
(LC50)	 and	 minimum	 inhibitory	 concentration	
(MIC).	 The	 trend	 line	 equation	 was	 calculated	
automatically	allowing	interpretation	of	resistance	
risk	level.	
RESULTS AND DISCUSSION
The	 stool	 tests	 were	 based	 on	 the	
morphostructural	 aspects	 of	 stage	 3	 larvae	
after	 14	 days	 of	 incubation.	 In	 the	 horse	 group,	
a	 predominance	 of	 the	 small	 strongyle	 species,	
especially	 those	 of	 the	 species	 Cyathostomum 
type	A	was	revelead	(53.40%)	and	Cyathostomum 
type	D	(with	a	percentage	of	25).	No	species	of	the	
Strongylidae	subfamily	were	identified,	confirming	
the	 international	 data	 reporting	 a	 decreased	
incidence	of	these	species	in	horses,	along	with	an	
increased	incidence	of	small	strongyles	(Cernea	et 
al.,	2010).
In	the	donkey	group,	a	predominance	of	small	
strongyles	 was	 observed	 (Cyathostomum	 type	 A	
29.33%,	Cyathostomum type	D	8%),	though	along	
with	 larger	 strongyles,	 mainly	 Triodontophorus 
spp.	 (1.33%).	 Furthermore,	 a	 high	 percentage	
of	 Trichostrongylus axei	 L3	 larvae	 was	 observed	
(37.33%)	 (Tab.	 1).	 The	 differences	 observed	
between	 the	 two	 equine	 species,	 in	 terms	 of	
digestive	strongyle	populations,	can	be	explained	
by	 owners’	 choice	 of	 excluding	 the	 donkeys	
from	 anthelmintic	 treatments.	 Thereby,	 due	 to	
interspecific	contamination,	the	donkey	strongyle	
species	 constitute	 a	 reservoir,	 unaltered	 by	 the	
anthelmintic	treatments.	Consequently,	regardless	
of	the	deworming	treatments	applied,		the	horses	
can	 be	 recontaminated	with	 resistant	 strongyles	
derived	 from	 the	 untreated	 donkeys,	 through	
cohabitation.	
FECRT	was	performed	using	a	fenbendazole-
based	 product.	 Before	 the	 treatment	 (BT)	
individual	 stool	 samples	 were	 collected.	
Afterwards,	 fenbendazole	 was	 administered	 in	
a	 dose	 of	 7,5	mg/kg	bw.	 14	days	 post-treatment	
(PT),	individual	stool	samples	were	collected	once	
again,	 determining	 EPG,	 the	 intensity	 and	 the	
extensivity	level.
In	 the	horse	group,	 the	average	 intensity	BT	
was	 1595.5	 EPG,	with	 a	maximum	of	 4000	 EPG.	
The	extensivity	level	BT	was	55%.	14	days	PT,	all	
stool	 samples	 were	 negative,	 reflecting	 the	 high	
efficacy	of	fenbendazole	(Tab.	2).
For	the	donkey	group,	results	were	different.	
The	 total	 EPG	 determined	 prior	 to	 treatment	
was	 6550,	 with	 an	 intensity	 of	 935.7	 and	 an	
extensivity	 of	 87.5%.	 The	 results,	 14	 days	 post-
treatment,	 showed	 an	 average	 intensity	 of	 150	
EPG	and	a	decline	of	the	extensivity	to	50%	(Tab.	
2).	 Fenbendazole	 proved	 to	 be	 less	 effective	
compared	to	the	horse	group,	even	if	the	donkey	
group	has	never	been	treated	with	anthelmintics.	
One	may	speculate	that	the	donkeys	were	infected	
with	resistant	equine	strongyles	from	the	horses.	
FECRT	 statistical	 interpretation	 presented	 a	
different	situation	between	the	two	groups.	Group	
1	 had	 a	 100	percentage	 of	 reduction,	 upper	 and	
lower	limits	of	95%	thrust	interval	being	null.	
This	 result	 highlights	 the	 maximum	
effectiveness	 of	 the	 fenbendazole	 anthelmintic	
treatment	 and	 the	 fact	 that	 the	 strongyle	
population	 found	 in	 horses	 was	 not	 resistant	 to	
fenbendazole.
Statistical	 analysis	 of	 the	 data	 obtained	 in	
the	 donkey	 group	 BT	 and	 PT	 showed	 a	 90.83	
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Tab. 2.	The	infestation	level	(EPG)	for	both	groups	before	treatment	(BT)	and	post-treatment	(PT) 
Group	1	-	horses EPG	BT EPG	PT Group	2	-	donkeys EPG	BT EPG	PT
1 4000 0 1 250 0
2 1400 0 2 1050 0
3 300 0 3 1000 0
4 3700 0 4 200 200
5 0 0 5 2650 100
6 550 0 6 200 100
7 700 0 7 1200 200
8 800 0 8 0 0
9 3400 0 Total 6550	EPG 600	OPG
10 2500 0 Intensity	 935.7	EPG 150	OPG
11 100 0 Extensivity 87.50	% 50%
12 100 0
13 0 0
14 0 0
15 0 0
16 0 0
17 0 0
18 0 0
19 0 0
20 0 0
Total 17550	EPG 0
Intensity	 1595.5	EPG 0
Extensivity 55% 0
Tab. 1. The	infestation	degree	and	the	strongyle	species	found	in	the	two	groups
Species
Group	1	-	horses Group	2	-	donkeys
Total	number	of	
identified	larvae	
Mean Percent
Total	number	of	
identified	larvae	
Mean Percent
Cyathostomum	A 47 2.35 53.4 22 2.75 29.33
Cyathostomum	B 0 0 0 0 0 0
Cyathostomum	C 9 0.45 10.2 2 0.25 2.67
Cyathostomum	D 22 1.1 25.0 6 0.75 8.00
Cyathostomum	E 0 0 0 0 0 0
Cyathostomum	F 6 0.3 6.8 5 0.63 6.67
Cyathostomum	G 3 0.15 3.4 0 0 0
Cyathostomum	H 0 0 0 0 0 0
Gyalocephalus	capitatus 1 0.05 1.1 0 0 0
Oesophagodontus	robustus 0 0 0 0 0 0
Poteriostomum 0 0 0 0 0 0
Crateorstomum	acuticadatum 0 0 0 0 0 0
Strongylus	equines 0 0 0 0 0 0
Strongylus	edentatus 0 0 0 0 0 0
Triodontophorus 0 0 0 1 0.13 1.33
Triodontophorus	serratus 0 0 0 0 0 0
Strongylus	vulgaris 0 0 0 0 0 0
Trichostrongylus	axei 0 0 0 28 3.50 37.33
Strongiloides	westeri 0 0 0 0 0 0
Free	nematodes 10 0.50 11.4 11 1.38 14.67
CĂTANĂ	et al
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percentage	of	reduction,	lower	than	the	minimum	
percentage	 accepted	 (95%).	 The	 confidence	
interval	95%	was	73%.	This	data	showed	that	the	
strongyle	population	found	in	the	donkey	group	is	
resistant	to	fenbendazole.	
The	 Egg	 Hatch	 Assay	 (EHA)	 for	 albendazole	
in	 horses	 showed	 a	 hatching	 percentage	 of	 100	
at	the	reference	concentration	and	the	LC
50
	64.32	
mcg/ml.	 The	 statistical	 analisys	 of	 the	 trend	
line	 equation	 and	 parameters	 a	 and	 b	 showed	
the	 correct	 hatching	 percentage	 of	 0.3740,	
much	 lower	 than	 the	accepted	 limit	of	50%.	The	
maximal	 value	 of	 Y	 paramether	 was	 -242.42,	
drawing	 a	 negative	 tendency	 for	 the	 trend	 line.	
All	data	shows	the	efficacy	of	albendazole	against	
the	strongyle	population	found	in	horses	(Tab.	3).	
Similar	results	were	obtained	for	fenbendazole	as	
well.	The	LC
50	
was	47.31	mcg/ml	and	the	hatching	
percentage	 at	 the	 reference	 concentration	 was	
0.0192.	The	Y	parameter	value	was	way	lower	than	
for	 albendazole,	 reaching	 -257.17	 and	 inducing	
a	 negative	 tendency	 for	 the	 trend	 line	 equation.	
This	test	confirms	the	results	obtained	by	FECRT	
proving	the	fenbendazole	efficacy.			
EHA	 showed	 a	 totally	 different	 situation	
for	 mebendazole	 compared	 to	 albendazole	 and	
fenbendazole.	 The	 hatching	 percentage	 at	 the	
reference	concentration	was	105.10,	showing	the	
weak	inhibitory	capacity	of	this	active	ingredient	
against	strongyle	eggs.	Even	if	LC
50	
had	a	negative	
value	of	 -0.1453	mcg/ml,	 corroborating	 the	data	
obtained	 at	 the	 hatching	 percentage	 shows	 us	
that,	in	order	to	obtain	a	positive	value	for	the	LC
50,	
the	 test	 should	 be	 made	 with	 active	 ingredient	
concentrations	 higher	 than	 5	 mcg/ml.	 These	
results	 have	 no	 practical	 relevance	 because	 of	
the	too	high	dosage.	The	trend	line	equation	had	
a	 high	 positive	 tendency,	 the	 maximal	 value	 for	
Y	 parameter	 being	 1009.92.	 Integrated	 analysis	
of	 obtained	 values	 shows	 a	 weak	 efficacy	 of	
mebendazole	 over	 strongyle	 population	 found	
in	 horses	 and	 the	 risk	 of	 inducing	 the	 adaptive	
phenomena	for	this	substance.	
EHA	 thiabendazole	 testing	 showed	 the	 best	
results,	but	we	have	 to	 take	 in	 consideration	 the	
fact	that,	because	of	its	capacity	to	delay	egg	hatch,	
this	active	ingredient	was	tested	only	as	standard	
(Cernea	et al.,	2010).	The	egg	hatch	percentage	at	
the	reference	concentration	was	11.62,	with	LC
50
 
of	 0.0086	 mcg/ml	 and	 the	 trend	 line	 equation	
with	a	powerful	negative	 tendency	 (Y	parameter	
=	-	1,305.1).
Tab. 3.	Group	1	EHA	results	for	ABZ	and	FBZ
Sample
A.i.	conc.
(mcg/ml)
ABZ FBZ
No.	of	eggs L1 Hatching	%
Trend	line	
equation
No.of	eggs L1 Hatching	%
Trend	line	
equation
1 5.0000 150 0 0.00 -242.42 50 50 50.00 -257.17
2 2.5000 50 0 0.00 -84.25 50 50 50.00 -100.22
3 1.2500 100 0 0.00 -5.16 0 150 100.00 -21.75
4 0.6250 150 0 0.00 34.39 0 150 100.00 17.49
5 0.3125 50 100 66.67 54.16 100 50 33.33 37.11
6 0.1563 0 100 100.00 64.04 100 0 0.00 46.92
7 0.0781 0 50 100.00 68.99 50 0 0.00 51.83
8 0.0391 0 100 100.00 71.46 0 50 100.00 54.28
9 0.0195 50 50 50.00 72.70 0 50 100.00 55.51
10 0.0098 50 50 50.00 73.31 100 0 0.00 56.11
HCL 0.0000 0 100 100.00 73.93 0 200 100.00 56.73
H2O 0.0000 0 50 100.00 0.00 100 0 0.00 0.00
Total 600 600 55.56 550 750 52.78
Parameters LC	50	(mcg)
Ref.	0.15	mcg/
ml	(%)
Parameters LC	50	(mcg)
Ref.	0.15	mcg/
ml	(%)
a -63.27 64.3208 0.3740 a -62.78 47.3100 0.0192
b 73.93 b 56.73
Note:	A.i.	conc.	=	active	ingredient	concentration,		LC
50	
=	lethal	concentration	50%,
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Even	 if	 the	 donkey	 and	 the	 horse	 group	 live	
in	the	same	environment,	EHA	results	for	the	two	
groups	 were	 totally	 different.	 This	 fact	 can	 be	
explained	by	 the	 lack	of	anthelmintic	 treatments	
in	the	donkey	group,	therefore	obtaining	different	
pharmacodynamic	results.
The	 albendazole	 EHA	 showed	 a	 hatching	
percentage	 of	 111.67	 at	 the	 reference	
concentration	 and	 LC
50
	 -0.54	mcg/ml.	 The	 trend	
line	 tendency	was	 positive	 reaching	 a	maximum	
value	 of	 541.82	 (Tab.	 5).	 This	 results	 show	 that	
albendazole	has	a	reduced	efficacy	against	donkey	
strongyles,	determining	a	major	predictive	risk	of	
inducing	the	resistance	phenomena.	
Fenbendazole	 EHA	 presented	 94.05	
egg	 hatching	 percentage,	 for	 the	 reference	
concentration,	a	lot	higher	than	the	accepted	value	
of	 50%.	 LC
50
	was	 2.43	mcg/ml,	 the	 Y	 parameter	
having	a	value	of	0.69.	Even	if	the	trend	line	had	a	
downward	tendency,	it	is	not	negative,	showing	a	
substantial	risk	of	strongyles	to	develop	adaptative	
phenomena	against	this	active	ingredient.		
For	mebendazole,	 in	 the	 donkey	 group,	 EHA	
showed	 an	 egg	 hatching	 percentage	 of	 87.51	 at	
the	reference	concentration,	LC
50
	being	1.20	mcg/
ml.	These	results	showed	a	reduced	efficacy.	Even	
so,	 compared	 to	 albendazole	 and	 fenbendazole	
tests,	 the	 risk	 of	 strongyles	 developing	 adaptive	
phenomena	 is	 lower.	The	Y	parameter	 showed	a	
value	of	-	85.15	and	the	trend	line	had	a	negative	
tendency.	 For	 thiabendazole	 the	 results	 were	
similar,	 the	 egg	hatching	percentage	being	73.93	
and	 the	LC
50
	 -0.085µg/ml,	with	a	highly	negative	
trend	line	tendency	(Y=	-1,840.17).
Larval	 development	 assay	 showed	 similar	
values	 in	 the	 horse	 group.	 MIC	 value	 was	 the	
same	(0.0489	mcg/ml).	The	sole	difference	noted	
regarded	 the	 Y	 parameter.	 For	 albendazole,	 this	
value	was	 -525.46,	 for	 fenbendazole	 -849.21	and	
-581.11	for	mebendazole	and	thiabendazole	(Tab.	
7	and	8).	In	horses,	all	LDA	results	showed	a	good	
efficacy	of	benzimidazoles	against	strongyle	eggs	
and	larvae	(Tab.	7	and	8).
For	all	benzimidazoles,	 the	risk	of	resistance	
is	 negligible,	 for	 fenbendazole	 being	 the	 lowest	
(Y	 -849.21).	 Therefore,	 treatment	 efficacy	would	
be	 greater	 if	 the	 therapeutic	 protocol	 would	
consider	a	sequential	administration	for	2-3	days	
or	repeating	it	at	7-14	days.	For	the	donkey	group,	
LDA	 had	 similar	 results	 as	 for	 the	 horse	 group.	
The	 Y	 parameter	 had	 a	 value	 of	 -1104.10	 for	
albendazole,	mebendazole	and	thiabendazole,	and	
lower	for	fenbendazole	(-1226.83)	(Tab.	9	and	10).
Tab. 4.	Group	1	EHA	results	for	MBZ	and	TBZ 
Sample	no.
A.i.	conc.
(mcg/ml)
MBZ TBZ
No.of	eggs L1 Hatching	%
Trend	line	
equation
No.of	eggs L1 Hatching % Trend	line	
equation
1 5.0000 150 100 40.00 1,009.92 500 0 0.00 -1,305.1
2 2.5000 0 150 100.00 543.52 500 50 9.09 -626.38
3 1.2500 100 450 81.82 310.32 250 0 0.00 -287.01
4 0.6250 0 100 100.00 193.72 450 0 0.00 -117.33
5 0.3125 0 100 100.00 135.42 400 0 0.00 -32.49
6 0.1563 0 50 100.00 106.28 350 0 0.00 9.92
7 0.0781 0 100 100.00 91.69 250 0 0.00 31.15
8 0.0391 0 50 100.00 84.41 250 50 16.67 41.73
9 0.0195 100 50 33.33 80.76 0 100 100.00 47.06
10 0.0098 0 50 100.00 78.95 0 100 100.00 49.69
HCL 0.0000 100 0 0.00 77.12 0 150 100.00 52.35
H2O 0.0000 50 50 50.00 0.00 50 100 66.67 0.00
Total 500 1250 75.43 3000 550 32.70
Parameters LC	50	(mcg)
Ref.	0.15	mcg/
ml	(%)
Parameters
LC	50	
(mcg)
Ref.	0.15	mcg/
ml	(%)
a 186.56 -0.1453 105.1000 a -271.49 0.0086 11.62
b 77.12 b 52.35
Note:	A.i.	conc.	=	active	ingredient	concentration,		LC
50
	=	lethal	concentration	50%,
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Minimum	 inhibitory	 concentration	 for	 all	
benzimidazoles	was	0.0489	mcg/ml,	proving	 the	
fact	 that,	 prolonging	 the	 contact	 time	 between	
exogenous	 parasitic	 forms	 and	 anthelmintics,	 a	
much	higher	effectiveness	is	obtained.	At	the	same	
time	 the	 predictive	 risk	 of	 resistance	 is	 greatly	
diminished,	 Y	 paramether	 showing	 a	 highly	
negative	trend	line	tendency.
Tab. 6.	Group	2	EHA	results	for	MBZ	and	TBZ
Sample	no.
A.i.	conc.
(mcg/ml)
MBZ TBZ
No.	of	eggs L1
Hatching	
%
Trend	line	
equation
No.	of	eggs L1 Hatching % Trend	line	
equation
1 5.0000 0 50 100.00 -85.15 50 0 0.00 -1,840.17
2 2.5000 0 50 100.00 3.85 150 0 0.00 -911.00
3 1.2500 0 250 100.00 48.35 50 0 0.00 -446.41
4 0.6250 0 50 100.00 70.60 50 0 0.00 -214.11
5 0.3125 50 0 0.00 81.73 50 0 0.00 -97.97
6 0.1563 0 100 100.00 87.29 50 0 0.00 -39.91
7 0.0781 0 100 100.00 90.07 150 0 0.00 -10.85
8 0.0391 0 100 100.00 91.46 50 0 0.00 3.65
9 0.0195 0 150 100.00 92.16 50 0 0.00 10.93
10 0.0098 0 50 100.00 92.50 50 0 0.00 14.54
HCL 0.0000 0 100 100.00 92.85 0 50 100.00 18.18
H2O 0.0000 0 50 100.00 0.00 0 50 100.00 0.00
Total 50 1050 91.67 700 100 16.67
Parameters LC	50	(mcg)
Ref.	0.15	mcg/
ml	(%)
Parameters LC	50	(mcg)
Ref.	0.15	mcg/
ml	(%)
a -35.6 1.2035 87.5100 a -371.67 -0.0856 73.9300
b 92.85 b 18.18
Note:	A.i.	conc.	=	active	ingredient	concentration,		LC	50	=	lethal	concentration	50,
Tab. 5.	Group	2	EHA	results	for	ABZ	and	FBZ
Sample	no.
A.i.	conc.
(mcg/ml)
ABZ FBZ
No.	of	eggs L1 Hatching	%
Trend	line	
equation
No.	of	eggs L1 Hatching % Trend	line	
equation
1 5.0000 150 0 0.00 541.82 0 50 100.00 0.69
2 2.5000 0 50 100.00 320.10 0 100 100.00 48.82
3 1.2500 0 50 100.00 209.23 0 150 100.00 72.88
4 0.6250 0 50 100.00 153.80 0 150 100.00 84.91
5 0.3125 0 100 100.00 126.09 0 50 100.00 90.92
6 0.1563 0 100 100.00 112.23 50 100 66.67 93.93
7 0.0781 0 50 100.00 105.30 0 100 100.00 95.44
8 0.0391 0 150 100.00 101.84 0 100 100.00 96.19
9 0.0195 0 100 100.00 100.10 0 150 100.00 96.56
10 0.0098 0 50 100.00 99.24 0 200 100.00 96.75
HCL 0.0000 0 150 100.00 98.37 0 50 100.00 96.94
H2O 0.0000 50 50 50.00 0.00 0 350 100.00 0.00
Total 200 900 87.50 50 1550 97.22
Parameters LC	50	(mcg)
Ref.	0.15	mcg/
ml	(%)
Parameters LC	50	(mcg)
Ref.	0.15	mcg/
ml	(%)
a 88.69 -0.5453 111.6700 a -19.25 2.4382 94.0555
b 98.37 b 96.94
Note:	A.i.	conc.	=	active	ingredient	concentration,		LC	50	=	lethal	concentration	50,
Benzimidazoles	Pharmacodynamics	in	Equine	Strongyles
366
Bulletin UASVM Veterinary Medicine 73 (2) / 2016
CONCLUSIONS
In	 the	 horse	 group,	 tested	 stool	 samples	
showed	 the	 predominance	 of	 small	 strongyles,	
especially	 those	 of	 Cyathostomum	 type	 A,	
Cyathostomum type	 D	 and	 Cyathostomum	 type	
C.	 After	 the	 fenbendazole	 treatment,	 all	 stool	
samples	were	negative,	showing	the	high	efficacy	
of	this	active	ingredient.	
In	the	donkey	group,	we	found	Trichostrongylus 
axei,	 Cyathostomum type	 A,	 Cyathostomum type	
Tab 7.	Group	1	LDA	results	for	ABZ	and	FBZ
A.i.	conc.	
(mcg/ml)
Sample	no.
ABZ FBZ
Eggs
+	L1
+	L2
L3 Development	%
Trend	line	
equation
Eggs
+	L1
+	L2
L3 Development	%
Trend	line	
equation
5.0000 1 250 0 0.00 -525.46 650 0 0.00 -849.21
2.5000 2 400 0 0.00 -260.14 150 0 0.00 -420.41
1.2500 3 50 0 0.00 -127.47 350 0 0.00 -206.01
0.6250 4 300 0 0.00 -61.14 450 0 0.00 -98.81
0.3125 5 350 0 0.00 -27.98 350 0 0.00 -45.21
0.1563 6 150 0 0.00 -11.40 300 0 0.00 -18.42
0.0781 7 650 0 0.00 -3.10 450 0 0.00 -5.01
0.0391 8 250 0 0.00 1.04 850 0 0.00 1.68
0.0195 9 100 0 0.00 3.12 250 0 0.00 5.05
0.0098 10 300 0 0.00 4.15 400 0 0.00 6.71
0.0000
Average	
H
2
O	+HCl
375 150 28.57 5.19 175 150 46.15 8.39
Total 3175 150 2.60 4375 150 4.20
MIC	-	mcg Parameters Parameters
0.0489
a -106.13 a -171.52
b 5.19 b 8.39
Note:	A.i.	conc.	=	active	ingredient	concentration,	MIC	=	Minimum	inhibitory	concentration
Tab 8. Group	1	LDA	results	for	MBZ	and	TBZ
A.i.	conc.	
(mcg/ml)
Sample	no.
MBZ TBZ
Eggs
+	L1
+	L2
L3 Development	%
Trend	line	
equation
Eggs
+	L1
+	L2
L3 Development	%
Trend	line	
equation
5.0000 1 100 0 0.00 -581.11 400 0 0.00 -581.11
2.5000 2 150 0 0.00 -287.69 450 0 0.00 -287.69
1.2500 3 200 0 0.00 -140.97 650 0 0.00 -140.97
0.6250 4 350 0 0.00 -67.62 250 0 0.00 -67.62
0.3125 5 800 0 0.00 -30.94 250 0 0.00 -30.94
0.1563 6 300 0 0.00 -12.60 300 0 0.00 -12.60
0.0781 7 400 0 0.00 -3.43 100 0 0.00 -3.43
0.0391 8 350 0 0.00 1.15 50 0 0.00 1.15
0.0195 9 150 0 0.00 3.45 200 0 0.00 3.45
0.0098 10 150 0 0.00 4.59 350 0 0.00 4.59
0.0000
Average	
H2O	+HCl
325 150 31.58 5.74 325 150 31.58 5.74
Total 3275 150 2.87 3325 150 2.87
MIC	-	mcg Parameters Parameters
0.0489
a -117.37 a -117.37
b 5.74 b 5.74
Note:	A.i.	conc.	=	active	ingredient	concentration,	MIC	=	Minimum	inhibitory	concentration
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D,	 but	 also	 Triodontophorus	 spp.	 Fenbendazole	
treatment	 had	 a	 reduced	 efficacy,	 the	 average	
intensity	being	150	EPG	and	the	extensivity	50%.
EHA	 revealed	 the	 efficacy	 of	 albendazole,	
fenbendazole	 and	 thiabendazole	 against	 the	
strongyles	 found	 in	 the	 horse	 group	 and	 the	
poor	 efficacy	 of	 mebendazole	 together	 with	 the	
risk	 of	 inducing	 adaptive	 phenomena.	 In	 the	
donkey	group,	EHA	showed	a	 low	efficacy	 for	all	
benzimidazoles	against	the	tested	strongyles.
LDA	 revealed	 that,	 in	 both	 groups,	
benzimidazoles	 inhibited	 larval	 development,	
with	high	efficacy.	
Predictive	 risk	 analysis	 showed	 the	 fact	
that	 new	 therapeutic	 protocols	 that	 provide	 a	
prolonged	contact	of	the	benzimidazoles	with	the	
parasitic	forms	should	be	performed.	Anthelmintic	
Tab 10.	Group	2	LDA	results	for	MBZ	and	TBZ
A.i.	conc.	
(mcg/ml)
Sample	no.
MBZ TBZ
Eggs
+	L1
+	L2
L3 Development	%
Trend	line	
equation
Eggs
+	L1
+	L2
L3 Development	%
Trend	line	
equation
5.0000 1 100 0 0.00 -1,104.10 250 0 0.00 -1,104.10
2.5000 2 50 0 0.00 -546.60 100 0 0.00 -546.60
1.2500 3 50 0 0.00 -267.85 50 0 0.00 -267.85
0.6250 4 100 0 0.00 -128.48 200 0 0.00 -128.48
0.3125 5 50 0 0.00 -58.79 150 0 0.00 -58.79
0.1563 6 50 0 0.00 -23.95 100 0 0.00 -23.95
0.0781 7 100 0 0.00 -6.52 100 0 0.00 -6.52
0.0391 8 150 0 0.00 2.18 100 0 0.00 2.18
0.0195 9 50 0 0.00 6.55 100 0 0.00 6.55
0.0098 10 100 0 0.00 8.71 200 0 0.00 8.71
0.0000
Average	
H2O	+HCl
100 150 60.00 10.90 100 150 60.00 10.90
Total 900 150 5.45 1450 150 5.45
MIC	-	mcg Parameters Parameters
0.0489 a -223 a -223b 10.9 b 10.9
Note:	A.i.	conc.	=	active	ingredient	concentration,	MIC	=	Minimum	inhibitory	concentration
Tab 9. Group	2	LDA	results	for	ABZ	and	FBZ
A.i.	conc.	
(mcg/ml)
Sample	no.
ABZ FBZ
Eggs
+	L1
+	L2
L3 Development	%
Trend	line	
equation
Eggs
+	L1
+	L2
L3
Development	
%
Trend	line	
equation
5.0000 1 50 0 0.00 -1,104.10 50 0 0.00 -1,226.83
2.5000 2 50 0 0.00 -546.60 50 0 0.00 -607.36
1.2500 3 100 0 0.00 -267.85 50 0 0.00 -297.62
0.6250 4 50 0 0.00 -128.48 100 0 0.00 -142.75
0.3125 5 50 0 0.00 -58.79 50 0 0.00 -65.31
0.1563 6 150 0 0.00 -23.95 100 0 0.00 -26.61
0.0781 7 200 0 0.00 -6.52 100 0 0.00 -7.23
0.0391 8 150 0 0.00 2.18 100 0 0.00 2.43
0.0195 9 50 0 0.00 6.55 150 0 0.00 7.29
0.0098 10 150 0 0.00 8.71 200 0 0.00 9.69
0.0000
Average	
H2O	+HCl
100 150 60.00 10.90 75 150 66.67 12.12
Total 1100 150 5.45 1025 150 6.06
MIC	-	mcg Parameters Parameters
0.0489
a -223 a -247.79
b 10.9 b 12.12
Note:	A.i.	conc.	=	active	ingredient	concentration,	MIC	=	Minimum	inhibitory	concentration
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treatments	 should	 be	 performed	 regularly	 and	
verified	using	both	in vitro	and	in vivo	tests.	
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